FerGene’s lead product is nadofaragene firadenovec, a gene therapy that uses a non-replicating adenovirus vector to deliver the gene for interferon alfa-2b into the bladder cells. After ...

Two main types of peginterferon-based regimens are currently available: alfa-2a and alfa-2b; which regimen is better is unknown. To address this issue, the IDEAL study team (supported by grants ...

The Dublin-based pharma is paying $15 million upfront for global rights to Werewolf's WTX-613, a prodrug of the cytokine interferon alfa-2b, which is still back n preclinical development and due ...

Interferon alfa-2b, recombinant; 18 million IU, 25 million IU; per vial; for inj; contains m-cresol. Interferons exert their cellular activities by binding to specific membrane receptors on the ...

The Phase I trial of the combination therapy has seen an approximate 66% rate of near-complete remission in its cohort of ...

50% of patients (3/6) with baseline HBsAg <1000 IU/mL achieved a functional cure (defined as sustained HBsAg loss and HBV DNA less than the lower limit of quantification (LLOQ) 24 weeks off all ...

CX-801 is a masked interferon alpha-2b PROBODY ® cytokine with broad potential applicability in traditionally immuno-oncology sensitive as well as insensitive (cold) tumors. CytomX has established ...